Skip Navigation
National Cancer Institute
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
 
OverviewProgramsAccomplishmentsEvent ListingNews and HighlightsPublished Research
 

Carolina Center of Cancer Nanotechnology Excellence
The University of North Carolina at Chapel Hill

Center Investigators

Joseph DeSimone, Ph.D.
Principal Investigator

 

Joel Tepper, M.D.
Principal Investigator

Cores

Core A: Analytical and Pharmacokinetics

Core Investigator: William Zamboni, Pharm. D, Ph.D.
This Core will perform in vitro and in vivo pharmacokinetics and pharmacodynamic studies of nanocarrier formulations of siRNA, platinum-analogues and taxane analogues. These studies will include pharmacokinetic studies of encapsulated, released and sum total (encapsulated + released) drug in plasma, tumor, and tissues and intracellular drug exposures. The core is also developing a high throughput screening platform to characterize and profile the interaction of nanoparticle agents and the mononuclear phagocyte system (MPS).

Core B: Targeting Ligand

Core Investigator: Rihe Liu, Ph.D.
The Core provides novel targeting ligands that can be used to direct nanoparticles to particular cancer cell types for Projects 1, 2, and 3.

Core C: Animal Imaging

Core Investigators: Weill Lin, Ph.D., Hong Yuan, Ph.D., and Dinggang Shen, Ph.D.
The Core provides novel non-invasive imaging approaches for determining bio-distribution other proposed nanoparticles and monitoring disease progression and therapeutic efficacy. In addition, image analysis tools will be developed to provide quantitative measures of biological parameters.